Dishman Carbogen [DCAL] vs Thyrocare [THYROCARE] Detailed Stock Comparison

Dishman Carbogen Amcis Ltd.

NSE
Loading...

Thyrocare Technologies Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dishman Carbogen Amcis Ltd. wins in 8 metrics, Thyrocare Technologies Ltd. wins in 11 metrics, with 0 ties. Thyrocare Technologies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dishman Carbogen Amcis Ltd. Thyrocare Technologies Ltd. Better
P/E Ratio (TTM) 22.30 45.42 Dishman Carbogen Amcis Ltd.
Price-to-Book Ratio 0.42 11.76 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 40.20 4.62 Thyrocare Technologies Ltd.
PEG Ratio -0.16 0.86 Thyrocare Technologies Ltd.
EV/EBITDA 9.62 25.65 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 4.25% 17.35% Thyrocare Technologies Ltd.
Operating Margin (TTM) 3.99% 18.51% Thyrocare Technologies Ltd.
EBITDA Margin (TTM) 3.99% 18.51% Thyrocare Technologies Ltd.
Return on Equity 0.06% 16.73% Thyrocare Technologies Ltd.
Return on Assets (TTM) 0.03% 13.21% Thyrocare Technologies Ltd.
Free Cash Flow (TTM) $1.58B $1.46B Dishman Carbogen Amcis Ltd.
Dividend Yield N/A 2.21% N/A
1-Year Return -33.95% 55.33% Thyrocare Technologies Ltd.
Price-to-Sales Ratio (TTM) 0.95 7.94 Dishman Carbogen Amcis Ltd.
Enterprise Value $46.55B $61.21B Thyrocare Technologies Ltd.
EV/Revenue Ratio 1.66 7.73 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) 80.34% 75.86% Dishman Carbogen Amcis Ltd.
Revenue per Share (TTM) $179 $51 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $7.58 $8.70 Thyrocare Technologies Ltd.
Beta (Stock Volatility) 0.40 0.28 Thyrocare Technologies Ltd.

Dishman Carbogen Amcis Ltd. vs Thyrocare Technologies Ltd. Stock Performance Analysis

Loading Price Chart...

DCAL
THYROCARE

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dishman Carbogen Amcis Ltd.-2.38%-2.24%-7.21%9.02%-19.76%-29.73%
Thyrocare Technologies Ltd.1.27%-1.06%15.89%48.78%23.90%19.90%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dishman Carbogen Amcis Ltd.-33.95%46.77%-6.77%33.46%290.77%118.12%
Thyrocare Technologies Ltd.55.33%231.85%23.21%170.47%153.71%153.71%

Performance & Financial Health Analysis: Dishman Carbogen Amcis Ltd. vs Thyrocare Technologies Ltd.

MetricDCALTHYROCARE
Market Information
Market Cap i₹26.50B₹62.88B
Market Cap CategorySmall capMid cap
10 Day Avg. Volume i337,264205,776
90 Day Avg. Volume i517,904271,331
Last Close₹180.24₹535.60
52 Week Range₹128.50 - ₹321.95₹318.07 - ₹578.25
% from 52W High-44.02%-7.38%
All-Time High₹396.40 (Jan 22, 2018)₹1,610.00 (Nov 18, 2025)
% from All-Time High-54.53%-66.73%
Growth Metrics
Quarterly Revenue Growth0.06%0.18%
Quarterly Earnings Growth-0.09%0.52%
Financial Health
Profit Margin (TTM) i0.04%0.17%
Operating Margin (TTM) i0.04%0.19%
Return on Equity (TTM) i0.00%0.17%
Debt to Equity (MRQ) i40.204.62
Cash & Liquidity
Book Value per Share (MRQ)₹405.67₹33.60
Cash per Share (MRQ)₹40.41₹12.09
Operating Cash Flow (TTM) i₹-199,700,000₹1.48B
Levered Free Cash Flow (TTM) i₹32.40M₹915.10M
Dividends
Last 12-Month Dividend Yield iN/A2.21%
Last 12-Month Dividend i₹0.00₹28.00

Valuation & Enterprise Metrics Analysis: Dishman Carbogen Amcis Ltd. vs Thyrocare Technologies Ltd.

MetricDCAL (Apr 26, 2026)THYROCARE (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i22.3045.42
Forward P/E i13.5232.93
PEG Ratio i-0.160.86
Price to Sales (TTM) i0.957.94
Price to Book (MRQ) i0.4211.76
Market Capitalization
Market Capitalization i₹26.50B₹62.88B
Enterprise Value i₹46.55B₹61.21B
Enterprise Value Metrics
Enterprise to Revenue i1.667.73
Enterprise to EBITDA i9.6225.65
Risk & Other Metrics
Beta i0.400.28
Book Value per Share (MRQ) i₹405.67₹33.60

Financial Statements Comparison: Dishman Carbogen Amcis Ltd. vs Thyrocare Technologies Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDCAL (2025)THYROCARE (2025)
Revenue/Sales i26.42B6.87B
Cost of Goods Sold i5.26B1.91B
COGS % of Revenue i19.9%27.8%
Gross Profit i21.16B4.96B
Gross Margin i80.1%72.2%
Research & Development iN/AN/A
Operating Income (EBIT) i1.46B1.36B
Operating Margin i5.5%19.8%
EBITDA i4.83B1.95B
EBITDA Margin i18.3%28.4%
Pre-Tax Income i193.10M1.45B
Pre-Tax Income % of Revenue i0.7%21.2%
Income Tax i160.70M546.90M
Income Tax % of Revenue i0.6%8.0%
Net Income (Profit) i32.40M907.50M
Profit Margin i0.1%13.2%

Balance Sheet & Liquidity Metrics

MetricDCAL (2025)THYROCARE (2025)
Cash & Equivalents i2.86B176.80M
Total Current Assets i22.00B3.38B
Total Current Assets % of Revenue i83.3%49.1%
Total Current Liabilities i19.25B1.22B
Total Current Liabilities % of Revenue i72.9%17.7%
Long-Term Debt i13.90B169.20M
Long-Term Debt % of Revenue i52.6%2.5%
Total Shareholders Equity i58.32B5.47B
Retained Earnings i2.13B3.15B
Retained Earnings % of Revenue i8.1%45.8%
Property, Plant & Equipment i10.27B1.84B

Cash Flow Statement Comparison

MetricDCAL (2025)THYROCARE (2025)
Operating Cash Flow i-199.70M1.48B
Operating Cash Flow % of Revenue i-0.8%21.5%
Capital Expenditures i-2.15B-448.80M
Free Cash Flow i1.58B1.46B
FCF Margin i6.0%21.3%
Debt Repayment i-1.10B-215.90M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDCALTHYROCARE
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i156.78M159.16M
Float Shares i54.95M62.01M
% Held by Insiders i69.30%61.09%
% Held by Institutions i2.41%20.22%
% Held by Public i28.29%18.69%

Dividend Analysis & Yield Comparison: Dishman Carbogen Amcis Ltd. vs Thyrocare Technologies Ltd.

MetricDCALTHYROCARE
Last 12-Month Dividend i₹0.00₹28.00
Last 12-Month Dividend Yield iN/A2.21%
3-Year Avg Annual Dividend i₹0.00₹21.33
3-Year Avg Dividend Yield iN/A2.02%
3-Year Total Dividends i₹0.00₹64.00
Ex-Dividend DateN/AOct 24, 2025